Clinical Trial Update: Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating interferon gamma-1b for leukocyte adhesion deficiency type I has completed. The study reports the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocyte Adhesion Deficiency Type

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Leukocyte Adhesion Deficiency Syndrome | Phase 2 | Status: COMPLETED